Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy demand has outpaced supply since its 2021 FDA approval, leaving many patients unable to fill prescriptions despite medical eligibility. Even when doctors are willing to prescribe, insurance coverage remains unpredictable, and prior authorization delays can stretch weeks. PlexusDx provides a direct path to semaglutide therapy without waiting for insurance approval or navigating pharmacy shortages.

Why Doctors Struggle to Prescribe Wegovy

Wegovy shortages began shortly after launch and have recurred multiple times due to manufacturing constraints at Novo Nordisk. Doctors cannot prescribe a medication their patients cannot obtain, forcing many to deny requests even when patients meet clinical criteria. This gap between demand and supply has persisted for over two years, affecting millions of patients seeking evidence-based weight loss treatment.

Insurance coverage adds a second barrier. Many health plans classify Wegovy as a weight loss cosmetic rather than metabolic disease treatment, requiring extensive prior authorization or refusing coverage outright. Some insurers demand failed attempts with older, less effective medications first. This gatekeeping delays treatment initiation by months and discourages doctors from writing prescriptions they know will be denied.

Prescription Requirements and Eligibility Criteria

The FDA approved Wegovy for patients with a body mass index (BMI) of 30 or higher, or a BMI of 27 with at least one weight-related medical condition such as hypertension, type 2 diabetes, or heart disease. Your doctor must evaluate your overall health, medication interactions, and personal or family history of thyroid cancer before initiating therapy. These medical safeguards exist because GLP-1 agonists work on appetite regulation pathways in the brain and pancreas.

Beyond BMI and comorbidities, doctors consider whether you have realistic expectations about weight loss timelines and whether you can commit to lifestyle changes alongside medication. Many physicians also screen for contraindications like personal history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Your doctor's hesitation may reflect appropriate clinical caution rather than inability or unwillingness to help.

Compounded Semaglutide as a Direct Alternative

PlexusDx compounded semaglutide injection offers the same active pharmaceutical ingredient as Wegovy, manufactured by licensed 503A compounding pharmacies that meet rigorous quality standards. Your dose may need to go up as your body adjusts to therapy, but your price won't—PlexusDx charges a flat $149 per month regardless of dose level. This transparent pricing eliminates surprise costs and ensures affordability remains constant throughout your treatment journey.

Compounded semaglutide bypasses insurance approval delays entirely. You can begin therapy within days of completing a medical consultation, accessing the same evidence-based mechanism that has helped millions achieve meaningful weight loss. PlexusDx serves all 50 states and accepts HSA and FSA funds, making medication cost eligible for tax-advantaged health accounts.

Understanding Your Personalized Response with Genetic Insight

Not all patients respond identically to semaglutide. Genetic variation in the GLP-1 receptor, GIPR pathway, and metabolic genes like FTO and MC4R influence how effectively your body signals fullness and burns calories. The PlexusDx Precision Peptide Genetic Test identifies your unique peptide-pathway variants across 14 biological mechanisms and 49 peptides, revealing which GLP-1 approach may work best for your genetic profile.

This genetic insight helps predict whether you'll benefit most from semaglutide alone, a dual-compound approach like GLP-Squared, or oral formulations. Understanding your genetic predispositions transforms weight loss from trial-and-error guessing into precision medicine tailored to your biology. The test costs just $99 as an add-on after your first month of treatment, giving you data-driven confidence in your therapy choice.

Getting Started Without Your Primary Doctor's Prescription

PlexusDx connects you with licensed healthcare providers who specialize in GLP-1 therapy and understand prescription barriers. Your initial consultation includes a complete medical history review, current medication screening, and eligibility assessment based on the same FDA criteria your primary care doctor would use. This ensures safety while removing the gatekeeping delays that frustrate patients.

Once approved, your prescription is filled by a licensed 503A compounding pharmacy and shipped directly to your home with no membership fees and no insurance required. You maintain contact with your PlexusDx care team for ongoing support, dose adjustments, and monitoring of side effects or metabolic improvements. Many patients use PlexusDx therapy while keeping their primary care doctor informed, integrating specialized GLP-1 care into their broader health management.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I use PlexusDx semaglutide if my doctor has already refused to prescribe Wegovy?

Yes. PlexusDx providers evaluate you independently using the same clinical criteria (BMI, comorbidities, medical history). Your previous doctor's decision doesn't prevent you from accessing compounded semaglutide—PlexusDx focuses on evidence-based eligibility, not insurance or supply constraints.

Is compounded semaglutide as safe and effective as brand-name Wegovy?

Compounded semaglutide contains identical active pharmaceutical ingredients and is manufactured by licensed 503A compounding pharmacies under strict quality standards. Clinical evidence shows that semaglutide—regardless of brand source—produces meaningful weight loss averaging 10-15% of body weight when combined with lifestyle changes, with effects observed in multiple large-scale trials.

What is the actual cost of PlexusDx semaglutide injections, and does it go up with higher doses?

PlexusDx semaglutide injection starts at $149 per month—a flat monthly fee that never changes regardless of your dose level. Your dose may need to go up as your body adjusts, but your price won't, ensuring predictable, transparent costs throughout treatment.

What side effects should I expect, and how do they compare to Wegovy?

Common side effects of semaglutide include nausea, vomiting, constipation, and appetite reduction—effects that typically diminish after 2-4 weeks as your body adjusts. Serious side effects are rare but can include pancreatitis or thyroid complications in patients with relevant history. PlexusDx providers monitor you closely and adjust doses gradually to minimize discomfort.

How can the Precision Peptide Genetic Test improve my weight loss results?

The PlexusDx Precision Peptide Genetic Test identifies your genetic variants in GLP-1 receptor, GIPR, FTO, and MC4R pathways across 14 metabolic mechanisms. This reveals whether you'll respond optimally to semaglutide alone, dual-compound GLP-Squared, or oral formulations—enabling truly personalized medicine instead of standard dosing. The test costs $99 after your first month.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves